Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

KREV vs. EMHY: which is better?

Bottom line

KREV vs EMHY: the short answer

KREV (KraneShares Global EM Revenue Leaders Index ETF) and EMHY (iShares J.P. Morgan EM High Yield Bond ETF) are both etfs.

EMHY is cheaper at 0.5% vs 0.65% — a difference of $15 a year per $10,000 invested.

Updated Nov 19, 2026

KREV vs EMHY side by side

KREVEMHY
TypeETFETF
Fund familyKrane SharesiShares
CategoryGlobal StockHigh-Yield Bond
Expense ratio0.65%0.5%
Annual cost per $10k$65$50
10-yr cost on $10k (prospectus)—$628
Max front loadNoneNone
12b-1 fee0%0%
1-yr return—+13.3%
5-yr return (annualized)—+4.0%
10-yr return (annualized)—+5.4%
Best quarter—+14.8%
Worst quarter—−18.8%
Net assets (fund)—$623.4M
Number of holdings—692
Portfolio turnover—32%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

KREV and EMHY share none of their top holdings.

KREV top 10

    EMHY top 10

    1. BlackRock Funds III — 7.80%
    2. Blackrock Cash Funds Treasury Sl Agency Shares — 2.00%
    3. Ind & Comm Bk Of China — 1.33%
    4. Ecuador Government International Bonds — 1.19%
    5. Argentina Republic Government International Bonds — 1.08%
    6. Ghana Government International Bonds — 0.87%
    7. Argentina Republic Government International Bonds — 0.63%
    8. Republic Of Ecuador — 0.58%
    9. Argentina Republic Government International Bonds — 0.57%
    10. Ecuador Government International Bonds — 0.52%

    FAQ

    What is the difference between KREV and EMHY?
    KREV (KraneShares Global EM Revenue Leaders Index ETF) and EMHY (iShares J.P. Morgan EM High Yield Bond ETF) are both etfs. EMHY is cheaper at 0.5% vs 0.65% — a difference of $15 a year per $10,000 invested.
    Which is cheaper, KREV or EMHY?
    EMHY has the lower expense ratio (0.5%).
    Should I own both KREV and EMHY?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.